JPH0522688B2 - - Google Patents

Info

Publication number
JPH0522688B2
JPH0522688B2 JP59252288A JP25228884A JPH0522688B2 JP H0522688 B2 JPH0522688 B2 JP H0522688B2 JP 59252288 A JP59252288 A JP 59252288A JP 25228884 A JP25228884 A JP 25228884A JP H0522688 B2 JPH0522688 B2 JP H0522688B2
Authority
JP
Japan
Prior art keywords
freeze
compound
stabilizer
hours
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59252288A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61130223A (ja
Inventor
Kazuhiro Shima
Koji Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP59252288A priority Critical patent/JPS61130223A/ja
Priority to FR8517383A priority patent/FR2573654B1/fr
Priority to GB08529182A priority patent/GB2167302B/en
Priority to DE19853541952 priority patent/DE3541952A1/de
Publication of JPS61130223A publication Critical patent/JPS61130223A/ja
Publication of JPH0522688B2 publication Critical patent/JPH0522688B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
JP59252288A 1984-11-28 1984-11-28 抗菌性凍結乾燥製剤 Granted JPS61130223A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP59252288A JPS61130223A (ja) 1984-11-28 1984-11-28 抗菌性凍結乾燥製剤
FR8517383A FR2573654B1 (fr) 1984-11-28 1985-11-25 Preparations antibacteriennes lyophilisees
GB08529182A GB2167302B (en) 1984-11-28 1985-11-27 Stable lyophilized antibacterial-preparations
DE19853541952 DE3541952A1 (de) 1984-11-28 1985-11-27 Lyophilisiertes, antibakterielles praeparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59252288A JPS61130223A (ja) 1984-11-28 1984-11-28 抗菌性凍結乾燥製剤

Publications (2)

Publication Number Publication Date
JPS61130223A JPS61130223A (ja) 1986-06-18
JPH0522688B2 true JPH0522688B2 (enrdf_load_stackoverflow) 1993-03-30

Family

ID=17235167

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59252288A Granted JPS61130223A (ja) 1984-11-28 1984-11-28 抗菌性凍結乾燥製剤

Country Status (4)

Country Link
JP (1) JPS61130223A (enrdf_load_stackoverflow)
DE (1) DE3541952A1 (enrdf_load_stackoverflow)
FR (1) FR2573654B1 (enrdf_load_stackoverflow)
GB (1) GB2167302B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
JP3072479B2 (ja) * 1997-06-10 2000-07-31 丸石自転車株式会社 車椅子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52143285A (en) * 1976-05-26 1977-11-29 Kikkoman Corp Stabilization of cholesterol-oxydase
JPS5962596A (ja) * 1982-09-30 1984-04-10 Shionogi & Co Ltd ビニルチオ化オキサセフアロスポリン誘導体
DK163000C (da) * 1982-09-30 1992-06-01 Shionogi & Co Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater
JPS59139323A (ja) * 1983-01-28 1984-08-10 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
JPS59196899A (ja) * 1983-04-20 1984-11-08 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの安定化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤

Also Published As

Publication number Publication date
GB2167302A (en) 1986-05-29
GB8529182D0 (en) 1986-01-02
DE3541952A1 (de) 1986-05-28
GB2167302B (en) 1988-08-10
FR2573654A1 (fr) 1986-05-30
FR2573654B1 (fr) 1987-05-07
JPS61130223A (ja) 1986-06-18

Similar Documents

Publication Publication Date Title
JPH0370688B2 (enrdf_load_stackoverflow)
AU758857B2 (en) Pharmaceutical compositions for freeze drying
JPS6364405B2 (enrdf_load_stackoverflow)
JP2958567B2 (ja) 非経口用凍結乾燥ｂｍｙ―２８１４２ジ塩酸塩
HU199686B (en) Process for producing combination of liophylized or precipitated diion forme and salt of cephalosporin
JPH0522688B2 (enrdf_load_stackoverflow)
US4222939A (en) Process for preparing solid sodium amoxycillin
KR930001830B1 (ko) 항균성 동결건조 제제
JP2761005B2 (ja) セファロスポリン含有注射用組成物
JPS5936616A (ja) セフアロスポリン誘導体の安定な医薬組成物
JP2004269401A (ja) 凍結乾燥製剤
HK1026366B (en) Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying